Breaking News
Global Pharma UpdatesFDA Approves New Groundbreaking Treatment for Autoimmune Diseases
Indian Healthcare TimesIndian Pharmaceutical Sector Sees 15% Export Growth in Q3
World Health ReportWHO Highlights Importance of Supply Chain Resilience in Medicine
PharmaTech InnovationsBreakthrough in API Manufacturing Reduces Production Costs by 20%
International Oncology DailyAdvances in Oncology: New Targeted Therapies Enter Phase 3 Trials
Global Health WatchGeneric Drug Accessibility Shows 30% Increase in Developing Nations
PharmaTech InsightsAI in Drug Discovery: Top Pharma Corporations Invest $2 Billion
EuroPharma NewsEuropean Medicines Agency Adjusts Guidelines for Biosimilars
CMO WeeklySustainability in Pharma: The Shift to Eco-Friendly Packaging
Wellness & ScienceRising Demand for Nutraceuticals Tops Record Highs This Year
Global Pharma UpdatesFDA Approves New Groundbreaking Treatment for Autoimmune Diseases
Indian Healthcare TimesIndian Pharmaceutical Sector Sees 15% Export Growth in Q3
World Health ReportWHO Highlights Importance of Supply Chain Resilience in Medicine
PharmaTech InnovationsBreakthrough in API Manufacturing Reduces Production Costs by 20%
International Oncology DailyAdvances in Oncology: New Targeted Therapies Enter Phase 3 Trials
Global Health WatchGeneric Drug Accessibility Shows 30% Increase in Developing Nations
PharmaTech InsightsAI in Drug Discovery: Top Pharma Corporations Invest $2 Billion
EuroPharma NewsEuropean Medicines Agency Adjusts Guidelines for Biosimilars
CMO WeeklySustainability in Pharma: The Shift to Eco-Friendly Packaging
Wellness & ScienceRising Demand for Nutraceuticals Tops Record Highs This Year
Global Pharma UpdatesFDA Approves New Groundbreaking Treatment for Autoimmune Diseases
Indian Healthcare TimesIndian Pharmaceutical Sector Sees 15% Export Growth in Q3
World Health ReportWHO Highlights Importance of Supply Chain Resilience in Medicine
PharmaTech InnovationsBreakthrough in API Manufacturing Reduces Production Costs by 20%
International Oncology DailyAdvances in Oncology: New Targeted Therapies Enter Phase 3 Trials
Global Health WatchGeneric Drug Accessibility Shows 30% Increase in Developing Nations
PharmaTech InsightsAI in Drug Discovery: Top Pharma Corporations Invest $2 Billion
EuroPharma NewsEuropean Medicines Agency Adjusts Guidelines for Biosimilars
CMO WeeklySustainability in Pharma: The Shift to Eco-Friendly Packaging
Wellness & ScienceRising Demand for Nutraceuticals Tops Record Highs This Year

Our Journey

Founded with a vision to revolutionize the pharmaceutical landscape, Sehwin Healthcare has grown from a local distributor to a pan-India pharmaceutical marketer. We specialize in providing a diverse range of therapeutic segments including Antibiotics, Analgesics, Multivitamins, and specialized Gynae formulations.

Our Mission

To provide high-quality, DCGI-approved formulations that improve patient outcomes without compromising affordability.

Our Vision

To be India's most trusted partner for healthcare professionals and pharma entrepreneurs by 2030.

Modern Pharmaceutical Facility
150+
Products in Portfolio
24+
States Covered
15+
Manufacturing Partners
5+
Years of Excellence

Core Values

The principles that guide every decision we make at Sehwin Healthcare.

Patient First

Every formulation is tested for safety and efficacy to ensure the best possible care for the end patient.

Integrity

We maintain complete transparency with our franchise partners and medical professionals.

Accessibility

Expanding our distribution network to ensure even the most remote areas have access to essential medicines.

Our Certifications

Committed to the highest standards of quality and safety in pharmaceutical manufacturing.

ISO 9001:2015

WHO-GMP Certified

DCGI Approved

FSSAI Registered

Leadership Team

The visionaries driving Sehwin Healthcare towards a healthier tomorrow.

Sh. Surinder Pal Singh

Director

Mrs. Monika

Head of Operations